CHRONIC MYELOMONOCYTIC LEUKEMIA-0

Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA-0 explained in plain language.

Never miss a new study

Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA-0 trials appear

Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA-0, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo tested for Hard-to-Treat blood cancers

Disease control Recruiting now

This study is testing a new oral drug, seclidemstat, combined with an existing drug, azacitidine, for adults with certain advanced blood cancers (MDS and CMML) that have not responded well to prior treatment. The main goals are to find the safest and most effective dose of the ne…

Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-0

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

CHRONIC MYELOMONOCYTIC LEUKEMIA-0

Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA-0 trials appear

New drug combo tested for Hard-to-Treat blood cancers